Tag | Content |
---|
EnhancerAtlas ID | HS007-10223 |
Organism | Homo sapiens |
Tissue/cell | BE2C |
Coordinate | chr20:46428970-46430000 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
INSM1 | MA0155.1 | chr20:46429410-46429422 | TGCCTGGGGGCA | + | 6.04 | Nkx2-5(var.2) | MA0503.1 | chr20:46429434-46429445 | CTTGAGTGCCT | - | 6.14 | RREB1 | MA0073.1 | chr20:46429933-46429953 | TGAGTGTAGGTGTGTTGGGG | - | 6.27 | ZNF143 | MA0088.2 | chr20:46429065-46429081 | CGGTGCTTTGTGGGAA | - | 6.57 |
|
| Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_43392 | chr20:46425289-46432944 | MCF-7 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | GCTGAGGGCT TCCTGCTGGG GCCACCCCCA CTCCAGGATT ATTTCATGCT GGTGCTCTGC 60 TATTGACTGT TGACAGGTGG GTCCCCCACC AGCCCCGGTG CTTTGTGGGA ACAGAGTCCT 120 GGCCCTCTCT GAGCCTGGCC TGGTGCTGTC TCAGAAGAGC CCATGGTCTG TGCTGAGCCA 180 GTGCAAGAGC AGAGTGGACC GCAGCTTCCT CCTCCACGGC ACTCCCGAAG CCCCTCGGGT 240 GACTCCGGCC AACCAGGTGT TCCAGCAGAG AGAAGGAGGA TTATGGGTGT GACTGTGGCC 300 CTTGTCCTTC CACGGCTCAG GCCGCACTGT GGGAGCTGGT CGCCTTTTAG CCTTTTAGCA 360 CTGGTCCATC CGTTTCTTTC CATTGCCCCG TGGAGTCTGT GGCCTTTTCT CCGGGTTCTG 420 ACTGAGACCA GAGTCCAGCC TGCCTGGGGG CAGTTGTACA CTGCCTTGAG TGCCTGGTGA 480 CAGGGTGACA GCACTGCCAG CGTCTCTGGG TTGGGTTTGG GGAGGCACCA GAGGCCTGAG 540 CAGACGGCTG GGGTTGGTTA TGGCTGCTGG GAAGGGCACA AAGCCAGGAG TGGGTGGGGC 600 AGGGAGACCA TGAGGAGCCT GTGCAGCCCG TTTTGTCTCA GCAGAGGGGC GAGTCCCAGT 660 AGCTTCCCCG GGCCAGGGCG TCAGCTGAGT CCTGGCAGTG CAGGCAGCCC CCAAGCTGGG 720 CATCTGGGCA GCAGGGAGGG GGGGGAGCTT CAGGGAGGAC GCGGTGGGTA GCACGTGTCT 780 CAGGGGACAC GTGTGCGTGT GAGAGGGTGA CAGTGTGTGT ATATGTGCGC CTATGAATGT 840 GTATGTGACT GTGTGCGTGA GAGTGAGGGT GTATGTGAGT CTGTACATGT GTGAATGTGT 900 GTATGTGTGT ATGTGAGTGT ATGAGCCTGT GTGTATGTAT GCATGTGTGT GTGAATGTAT 960 GTGTGAGTGT AGGTGTGTTG GGGCCTGTGT GCGTGTATGT GTGCGTGAAT GTGTGTAAGT 1020 GTAGGTGTAT 1030
|